Recovery & Repair

KPV Peptide UAE: Anti-Inflammatory Tripeptide Research Guide and Where to Buy (2026)

· · 5 min read
KPV anti-inflammatory tripeptide alpha-MSH research UAE Dubai
!
💡What You’ll Learn
  • Key Facts at a Glance
  • What Is KPV?
  • How Does KPV Work?
  • KPV Research: Key Studies
  • KPV in the Klow Blend
🔄 Last updated: May 12, 2026
5 min read|1,024 words

In the growing field of anti-inflammatory and gut health peptide research, KPV stands out as one of the most targeted and mechanistically specific compounds available. A tripeptide derived from the C-terminal sequence of alpha-melanocyte stimulating hormone (α-MSH), KPV retains the potent anti-inflammatory properties of its parent molecule while being small enough to potentially cross biological barriers that larger peptides cannot.

02

What Is KPV?

KPV is a tripeptide composed of three amino acids: Lysine-Proline-Valine (Lys-Pro-Val). It represents the C-terminal tripeptide fragment of alpha-MSH — specifically the sequence at positions 11-13. Despite its tiny size (MW: 340.4 Da), KPV is a potent melanocortin receptor agonist with particularly strong affinity for MC1R and MC3R — the receptor subtypes most strongly associated with anti-inflammatory and immune-modulating effects.

KPV’s small molecular weight is a significant research advantage: it can potentially penetrate cell membranes and cross barriers that exclude larger peptides, and it is highly stable in physiological conditions compared to full-length α-MSH.

03 · Work

How Does KPV Work?

📬
Stay Updated on Peptide Research

Latest research insights. No spam, ever.

TL;DR. KPV inhibits NF-κB nuclear translocation — the master regulator of inflammatory cytokine genes. Block NF-κB and you shut down TNF-α, IL-6, IL-1β production at the source. Unlike steroids, it doesn’t suppress general immune function.
  • MC1R and MC3R agonism: KPV activates melanocortin receptors on immune cells, triggering anti-inflammatory signalling cascades
  • NF-κB inhibition: Research shows KPV directly inhibits NF-κB nuclear translocation — blocking one of the primary transcription factors driving inflammatory cytokine production
  • Cytokine suppression: KPV reduces production of pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β in multiple research models
  • Intracellular penetration: Research has shown KPV can enter cells directly and inhibit inflammatory pathways intracellularly — a mechanism not available to most peptides
  • Gut epithelial protection: In intestinal research models, KPV reduces mucosal inflammation and supports epithelial barrier integrity

04 · Research

KPV Research: Key Studies

TL;DR. Three major application areas: IBD/colitis models (NF-κB inhibition in the gut), skin inflammation, systemic anti-inflammatory studies. The Cone Laboratory at Stanford has done much of the foundational research on the C-terminal α-MSH fragment.

Inflammatory Bowel Disease Models

KPV has been most extensively studied in models of intestinal inflammation. Research published in the Journal of Pharmacology and Experimental Therapeutics demonstrated that KPV significantly reduced colonic inflammation in experimental colitis models, with reductions in mucosal cytokine levels, inflammatory cell infiltration, and tissue damage scores. Oral and local colonic delivery have both been investigated, with promising results for gut-targeted research applications.

Skin Inflammation Research

As an α-MSH fragment, KPV has been studied in skin inflammation models including psoriasis and eczema analogues. Research demonstrated significant reductions in keratinocyte inflammatory cytokine production and immune cell infiltration, with effects mediated through MC1R on skin cells and tissue-resident immune cells.

Systemic Anti-Inflammatory Effects

Beyond local tissue effects, KPV has demonstrated systemic anti-inflammatory activity in animal models of sepsis and systemic inflammation. Research showed KPV reduced mortality, cytokine storm markers, and organ damage in LPS-induced inflammation models — establishing its potential as a broad-spectrum anti-inflammatory research compound.

05 · Klow

KPV in the Klow Blend

Emirates Peptides features KPV as one of four active peptides in the Klow Blend (BPC-157 / TB-500 / KPV / GHK-Cu) — a comprehensive tissue repair and anti-inflammatory research stack combining complementary mechanisms in a single vial.

06 · Research

Research Dosing (Reference)

Research use only. Typical dose 200–500 mcg subcutaneous or oral daily. KPV’s small size allows oral administration with reasonable bioavailability in research models. Not medical guidance.

For research reference only.

In animal research models, KPV has been administered at doses ranging from 10mcg to 300mcg/kg via subcutaneous, intraperitoneal, and oral routes. Its small size makes it one of the few peptides with potential oral bioavailability, though subcutaneous injection remains most common in research. Emirates Peptides supplies KPV in 10mg vials.

Storage

Item 01

Lyophilised:

2-8°C, stable up to 12 months

Item 02

Reconstituted:

2-8°C, use within 30 days

07

Where to Buy KPV in the UAE

  • ✅ COA-verified, ≥99% purity
  • ✅ 10mg vials
  • ✅ Fast delivery to Dubai, Abu Dhabi and all UAE emirates
  • ✅ GCC shipping available
  • ✅ Cash on delivery in Dubai

Order KPV in UAE →

08 · Questions

Frequently Asked Questions

What does KPV stand for?

KPV is the three-letter amino acid sequence: Lysine-Proline-Valine. It’s the C-terminal tripeptide fragment of alpha-melanocyte stimulating hormone (α-MSH) and retains the anti-inflammatory activity of the parent peptide.

How is KPV different from corticosteroids?

Corticosteroids suppress the entire immune system, with significant systemic side effects. KPV specifically inhibits NF-κB nuclear translocation in inflammation-producing cells — blocking the inflammatory cytokine cascade without broad immunosuppression. This makes it the cleaner research tool for inflammation studies.

Can KPV be taken orally?

Yes — KPV’s small tripeptide size gives it unusually good oral bioavailability for a peptide. Research models show meaningful anti-inflammatory action via oral administration. This is one of the reasons it’s particularly suited to IBD research, where oral delivery to the gut is desirable.

What is the typical KPV research dose?

Published research uses 200–500 mcg daily — subcutaneous, oral, or topical depending on the endpoint. IBD models typically use oral or rectal administration; systemic anti-inflammatory studies use subcutaneous.

Why is KPV part of the Klow Blend?

KPV adds clean anti-inflammatory action to the BPC-157 + TB-500 + GHK-Cu base. The other three drive tissue repair; KPV controls inflammation. The combination makes Klow Blend particularly relevant for IBD and systemic inflammation research where both repair and inflammation control matter.

KPV is supplied strictly for laboratory research use and is not a controlled substance in the UAE.

Disclaimer: For laboratory research use only. Not approved for human use. Not medical advice.

Was this article helpful?

Emirates Peptides Research Team

Emirates Peptides Research Team curates evidence-based content on peptide science for research professionals across the UAE and beyond.

Share this article

Emirates Peptides Research Team

Scientific Content

Our research team curates evidence-based content on peptide science, ensuring all articles are grounded in peer-reviewed literature and current scientific understanding. All products are for laboratory research use only.

Explore Research-Grade Peptides

HPLC-verified, lab-tested peptides for your scientific research. Fast delivery across the UAE.

Browse All Peptides

Selected Research References

Selected scientific references for research context only. Products remain for laboratory research use and are not for human use.

  1. Alpha-melanocyte-stimulating hormone and related tripeptides (PMID: 18612139; DOI: 10.1210/er.2007-0027)
  2. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease (PMID: 18092346; DOI: 10.1002/ibd.20334)
  3. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis (PMID: 28143741)
  4. Therapeutic peptides: current applications and future directions (PMID: 35165272; DOI: 10.1038/s41392-022-00904-4)
Reviewer
Medical Reviewer

Emirates Peptides Research Team

A dedicated coalition of biochemists and clinical researchers focusing on advanced peptide synthesis and pharmacological applications. All data is verified against current clinical trials.